Literature DB >> 33247821

Therapeutic optimization through goal-oriented prescription in nursing homes.

N Molist-Brunet1,2, D Sevilla-Sánchez3,4, J González-Bueno3,4, V Garcia-Sánchez5, L A Segura-Martín6, C Codina-Jané3,4, J Espaulella-Panicot7,3,8.   

Abstract

Background People living in nursing homes are highly vulnerable and frail. Polypharmacy and inappropriate prescription (IP) are also common problems. Objectives The objectives of the study are (i) to study the baseline situation and calculate the frailty index (FI) of the residents, (ii) to assess the results of routine clinical practice to do a pharmacotherapy review (patient-centred prescription (PCP) model) (Molist Brunet et al., Eur Geriatr Med. 2015;6:565-9) and (iii) to study the relationship between IP and frailty, functional dependence, advanced dementia and end-of-life situation. Setting Two nursing homes in the same geographical area in Catalonia (Spain). Method This was a prospective, descriptive and observational study of elderly nursing home residents. Each patient's treatment was analysed by applying the PCP model, which centres therapeutic decisions on the patient's global assessment and individual therapeutic goal. Main outcome measure Prevalence of polypharmacy and IP. Results 103 patients were included. They were characterized by high multimorbidity and frailty. Up to 59.2% were totally dependent. At least one IP was identified in 92.2% of residents. Prior to the pharmacological review, the mean number of chronic medications prescribed per resident was 6.63 (SD 2.93) and after this review it was 4.97 (SD 2.88). Polypharmacy decreased from 72.55% to 52.94% and excessive polypharmacy fell from 18.62% to 5.88%.The highest prevalence of IP was detected in people with a higher FI, in those identified as end-of-life, and also in more highly dependent residents (p < 0.05). Conclusions People who live in nursing homes have an advanced frailty. Establishing individualized therapeutic objectives with the application of the PCP model enabled to detect 92.2% of IP. People who are frailer, are functionally more dependent and those who are end-of-life are prescribed with inappropriate medication more frequently.
© 2020. The Author(s).

Entities:  

Keywords:  Goal-oriented prescription; Inappropriate prescription; Nursing homes; Polypharmacy

Year:  2020        PMID: 33247821     DOI: 10.1007/s11096-020-01206-x

Source DB:  PubMed          Journal:  Int J Clin Pharm


  3 in total

1.  Overuse of antipsychotic medication in elderly people with dementia? A view from general practice.

Authors:  Harm van Marwijk; Wolfgang Spiegel
Journal:  Ment Health Fam Med       Date:  2009-12

Review 2.  Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline.

Authors:  Lise M Bjerre; Barbara Farrell; Matthew Hogel; Lyla Graham; Geneviève Lemay; Lisa McCarthy; Lalitha Raman-Wilms; Carlos Rojas-Fernandez; Samir Sinha; Wade Thompson; Vivian Welch; Andrew Wiens
Journal:  Can Fam Physician       Date:  2018-01       Impact factor: 3.275

3.  Outcome of comprehensive medical rehabilitation: measurement by PULSES profile and the Barthel Index.

Authors:  C V Granger; G L Albrecht; B B Hamilton
Journal:  Arch Phys Med Rehabil       Date:  1979-04       Impact factor: 3.966

  3 in total
  3 in total

1.  Methodological Challenges for Epidemiologic Studies of Deprescribing at the End of Life.

Authors:  Jennifer Tjia; Jennifer L Lund; Deborah S Mack; Attah Mbrah; Yiyang Yuan; Qiaoxi Chen; Seun Osundolire; Cara L McDermott
Journal:  Curr Epidemiol Rep       Date:  2021-04-23

2.  Improving individualized prescription in patients with multimorbidity through medication review.

Authors:  Núria Molist-Brunet; Daniel Sevilla-Sánchez; Emma Puigoriol-Juvanteny; Matilde Barneto-Soto; Javier González-Bueno; Joan Espaulella-Panicot
Journal:  BMC Geriatr       Date:  2022-05-12       Impact factor: 4.070

3.  Individualized Medication Review in Older People with Multimorbidity: A Comparative Analysis between Patients Living at Home and in a Nursing Home.

Authors:  Núria Molist-Brunet; Daniel Sevilla-Sánchez; Emma Puigoriol-Juvanteny; Lorena Bajo-Peñas; Immaculada Cantizano-Baldo; Laia Cabanas-Collell; Joan Espaulella-Panicot
Journal:  Int J Environ Res Public Health       Date:  2022-03-14       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.